A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Discover a study where results suggest a statistically significant association between dupilumab and psoriasis, although the clinical impact may be limited.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of ...

Nektar Therapeutics said on Tuesday its experimental eczema drug had met the main goal of a mid-stage study.In the 393-patient trial, drug candidate rezpegaldesleukin showed a reduction in the ...

Nektar Therapeutics stock launched Tuesday after the biotech company hit every goal in a midstage study of its eczema ...

In trials, Sotyktu was found to be more effective at treating moderate-to-severe psoriasis than Amgen’s PDE4 inhibitor Otezla (apremilast), which was recommended by NICE for a similar patient ...

The CHMP has backed LEO Pharma's delgocitinib for chronic hand eczema, considered to be one of its top pipeline prospects. Skip to main content Wednesday 25 June 2025 . BlueSky linkedin youtube ...

You've seen plenty of ads for anti-wrinkle creams that promise to make you look years younger and help reduce wrinkles and fine lines. Consumer Reports tests to see if you, too, can have cover ...